Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1827|65|6|286-292

ISSN： 1320-5463

Source： PATHOLOGY INTERNATIONAL, Vol.65, Iss.6, 2015-06, pp. : 286-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 4, 2015-04 ,pp. : 271-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

GATA3: A promising marker for metastatic breast carcinoma in serous effusion specimens

By  

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 4, 2014-04 ,pp. : 307-312

John Wiley & Sons Inc

Access to resources Recommend Favorite

GATA‐binding protein 3, gross cystic disease fluid protein‐15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups

By  

HISTOPATHOLOGY, Vol. 67, Iss. 1, 2015-07 ,pp. : 96-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens

By  

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 6, 2014-06 ,pp. : 468-473

John Wiley & Sons Inc

Access to resources Recommend Favorite

Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 10, 2015-10 ,pp. : 576-581

John Wiley & Sons Inc

Access to resources Recommend Favorite